Envirotech Vehicles appoints Jason Maddox to board of directors
Investing.com -- PetMed Express (NASDAQ:PETS) stock fell 15% in after-hours trading Tuesday following the announcement that both its Chief Executive Officer and Chief Financial Officer have resigned from the company.
The pet medication retailer disclosed that CEO Sandra Campos and CFO Robyn D’Elia have both stepped down from their positions and employment with the company. In response to these sudden leadership changes, Board Chair Leslie C.G. Campbell has assumed the role of Interim Chief Executive Officer, while Chief Accounting Officer Douglas Krulik will serve as Interim Principal Financial (NASDAQ:PFG) Officer.
According to the company’s statement, both executives entered into separation agreements on August 11, 2025, which include severance payments consisting of 13 months of their current base salaries and accelerated vesting of a portion of their unvested restricted stock units. The departing executives have also agreed to provide consulting services to PetMed Express for three months on an as-needed basis.
As part of the leadership transition, Campos has also resigned from the Board of Directors, which has been reduced to five members. Campbell will remain as Board Chair but will step down from the Audit Committee and the Compensation and Human Capital Committee. Justin Mennen has been appointed as Lead Independent (LON:IOG) Director, while Peter Batushansky and Leah Solivan will chair the Audit Committee and Compensation and Human Capital Committee, respectively.
The company has initiated a search for permanent replacements for both the CEO and CFO positions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.